The opinions of the Independent Financial Advisor on the connected transaction (For the purpose of translation only) 0 The opinions of the Independent Financial Advisor on the connected transaction
around Baht 6.99 million in sales promotion expense, expense on hiring of OTC team, cost of exhibition booth display and sample products, etc. and an increase of about Baht 3.15 million in salary and car
compensation for distribution of the Company’s products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig
products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig Pharma Ltd. took effect as from September 1
products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig Pharma Ltd. took effect as from September 1
ครบถ้วน กองทุนเปิดไทยพาณิชย์ Autonomous Technology and Robotics SCB Autonomous Technology and Robotics (SCBAUTO)
Date on April 1, 2018) Director/ Independent Director/ Chairman of the Board 1. Dr. Pornchai Chunhachinda Director/ Independent Director/ Chairman of the Board 2. Mr. Atsadang Sresuphornpan (Effective
3 February 2020 respectively due to the Company and the Independent Financial Advisor are still preparing significant information and documents resulting that information and documents will not be
3 February 2020 respectively due to the Company and the Independent Financial Advisor are still preparing significant information and documents resulting that information and documents will not be
Public Hearing System :: สำนักงานคณะกรรมกำกับหลักทรัพย์และตลาดหลักทรัพย์ แบบสำรวจความคิดเห็น Hearing Home การสนับสนุนให้เกิดผู้ให้คำแนะนำการลงทุนที่เป็นอิสระ (independent investment advisor